Goh Tanaka
Overview
Explore the profile of Goh Tanaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujioka H, Kikuchi K, Nakahara T, Yoshioka S, Kawai R, Kajitani M, et al.
Intern Med
. 2025 Mar;
PMID: 40058855
Advancements in immunotherapy, the phenomenon of hyperprogression in cancer patients, have garnered increasing attention. We herein report a case of acute adult T-cell leukemia/lymphoma (ATL) that developed after administration of...
2.
Kimura Y, Jo T, Hashimoto Y, Kumazawa R, Ishimaru M, Matsui H, et al.
ERJ Open Res
. 2025 Jan;
11(1).
PMID: 39872388
https://bit.ly/3Z7uBkg.
3.
Takeda K, Yokoyama A, Fukami T, Kimura Y, Suzukawa M, Jo T, et al.
Med Mycol
. 2024 Dec;
62(12).
PMID: 39657982
Postoperative complications of pulmonary resection in patients with pulmonary aspergilloma are common. Preoperative antifungal therapy is a perioperative management strategy to reduce postoperative complications; however, the benefit of the treatment...
4.
Kimura Y, Sasabuchi Y, Jo T, Hashimoto Y, Kumazawa R, Ishimaru M, et al.
Respir Investig
. 2024 Oct;
62(6):1102-1108.
PMID: 39357113
Background: Chronic pulmonary aspergillosis (CPA) has recently gained attention owing to its substantial health burden. However, the precise epidemiology and prognosis of the disease are still unclear due to the...
5.
Kimura Y, Suzukawa M, Jo T, Hashimoto Y, Kumazawa R, Ishimaru M, et al.
ERJ Open Res
. 2024 Aug;
10(4).
PMID: 39135663
Background: The 2014 European Respiratory Society/American Thoracic Society guidelines defined severe asthma based on treatment intensity and estimated the proportion of severe asthma among all asthma cases to be 5-10%....
6.
Tamiya H, Jo T, Yokoyama A, Sakamoto Y, Mitani A, Tanaka G, et al.
Eur J Cardiothorac Surg
. 2024 Jul;
66(1).
PMID: 38979769
Objectives: Although intrapleural administration of fibrinolytics is an important treatment option for the management of empyema, the addition of fibrinolytics failed to reduce the need for surgery and mortality in...
7.
Kimura Y, Jo T, Inoue N, Suzukawa M, Hashimoto Y, Kumazawa R, et al.
J Allergy Clin Immunol Pract
. 2024 May;
12(8):2035-2044.
PMID: 38734374
Background: Similar to metformin, dipeptidyl peptidase-4 inhibitors (DPP-4 Is), glucagon-like peptidase 1 receptor agonists (GLP-1 RAs), and sodium glucose co-transporter-2 inhibitors (SGLT-2 Is) may improve control of asthma owing to...
8.
Kimura Y, Jo T, Hashimoto Y, Kumazawa R, Ishimaru M, Matsui H, et al.
Respir Investig
. 2024 Apr;
62(3):494-502.
PMID: 38583226
Background: Using patient registries or limited regional hospitalization data may result in underestimation of the incidence and prevalence of rare diseases. Therefore, we used the national administrative database to estimate...
9.
Kimura Y, Suzukawa M, Jo T, Hashimoto Y, Kumazawa R, Ishimaru M, et al.
Allergy
. 2024 Jan;
79(6):1598-1602.
PMID: 38186054
No abstract available.
10.
Fujii K, Fukuda K, Kawakami M, Mitani A, Tanaka G, Kage H
Case Rep Oncol
. 2023 Oct;
16(1):907-911.
PMID: 37900823
A man in his late 40s was diagnosed with clinical stage 4B lung adenocarcinoma with a PD-L1 tumor proportion score of 100% and high tumor mutational burden. A partial response...